NAGE

Niagen Bioscience, Inc. Common Stock
NAGE

Overview Fund Activity

46 hedge funds and large institutions have $13.6M invested in Niagen Bioscience, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-6
Holders Change %
-11.54%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
16
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$3.27M
2
TCM
Tieton Capital Management
Washington
+$1.85M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$105K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$82.9K
5
Barclays
Barclays
United Kingdom
+$29.6K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$198K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$188K
3
NSIM
North Star Investment Management
Illinois
-$161K
4
Morgan Stanley
Morgan Stanley
New York
-$122K
5
US Bancorp
US Bancorp
Minnesota
-$75K
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
51
Credit Suisse
Switzerland
– -$37K -11,271 Closed
Northwestern Mutual Wealth Management
52
Northwestern Mutual Wealth Management
Wisconsin
– -$12K -3,754 Closed
FANJ
53
Financial Architects (New Jersey)
New Jersey
– -$3K -1,000 Closed
TRCT
54
Tower Research Capital (TRC)
New York
– -$2K -572 Closed
1 2
3